Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
http://www.nejm.org/multimedia/audio-interview
Gesamtlänge aller Episoden: 8 days 30 minutes
Dr. Christopher Dale on better ways of deploying quality metrics to improve the value of health care.
Christopher Dale is Medical Director of Quality and Value for Swedish Medical Group in Seattle. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.R. Dale, M. Myint, and A.L. Compton-Phillips. Counting Better — The Limits and Future of Quality-Based Compensation. N Engl J Med 2016;375:609-11.
Dr. Scott Podolsky on the evolution of the essential methods of randomized, controlled trials.
Dr. Scott Podolsky is an associate professor of global health and social medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. L.E. Bothwell and S.H. Podolsky. History of Clinical Trials: The Emergence of the Randomized, Controlled Trial. N Engl J Med 2016;375:501-4.
Dr. Harlan Krumholz on the movement toward broader, responsible, productive sharing of data from clinical trials.
Dr. Harlan Krumholz is a professor of medicine and epidemiology and public health at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. H.M. Krumholz and J. Waldstreicher. The Yale Open Data Access (YODA) Project — A Mechanism for Data Sharing. N Engl J Med 2016;375:403-5.
Dr. Alan D.T. Barrett on the current yellow fever epidemic and lessons about vaccine supply and global health.
Dr. Alan D.T. Barrett is the director of the Sealy Center for Vaccine Development and professor in the Departments of Pathology and of Microbiology and Immunology at the University of Texas Medical Branch. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A.D.T. Barrett. Yellow Fever in Angola and Beyond — The Problem of Vaccine Supply and Demand. N Engl J Med 2016;375:301-3.
Dr. Benjamin Sommers on the future cost of insurance coverage under the Affordable Care Act.
Dr. Benjamin Sommers is an assistant professor of health policy and economics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. B.D. Sommers. Obamacare’s Skyrocketing Premiums? Why the Sky Isn’t Falling. N Engl J Med 2016;375:201-3.
Dr. Alisha Rankin on the clinical trials and drug approval processes of the 16th through 18th centuries.
Dr. Alisha Rankin is an associate professor of history at Tufts University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Rankin and J. Rivest. History of Clinical Trials: Medicine, Monopoly, and the Premodern State — Early Clinical Trials. N Engl J Med 2016;375:106-9.
Dr. Eric Rubin on the current state of the Zika epidemic and directions for research and prevention.
Dr. Eric Rubin is a professor of immunology and infectious diseases at the Harvard T.H. Chan School of Public Health and an associate editor at the Journal. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. M.A. Johansson and Others. Zika and the Risk of Microcephaly. N Engl J Med 2016;375:1-4.
Dr. José Jerónimo on approaches to reducing rates of cervical cancer in low- and middle-income countries.
Dr. José Jerónimo is senior advisor for women’s cancers with the Reproductive Health Program at PATH (formerly the Program for Appropriate Technology in Health) in Seattle. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. V. Tsu and J. Jerónimo. Saving the World’s Women from Cervical Cancer. N Engl J Med 2016;374:2509-11.
Dr. Jeffrey Drazen on evolving efforts to make clinical trials data accessible and useful for further research.
Dr. Jeffrey Drazen is Editor-in-Chief of the Journal. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.J. Haug. From Patient to Patient — Sharing the Data from Clinical Trials. N Engl J Med 2016;374:2409-11.
Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.
Dr. Ameet Sarpatwari is an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Sarpatwari, J. Avorn, and A.S. Kesselheim. State Initiatives to Control Medication Costs — Can Transparency Legislation Help? N Engl J Med 2016;374:2301-4.